Search Results 51-60 of 4466 for Diffuse
... Diffuse Large B-cell Lymphoma (R/R DLBCL). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...
This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory diffuse ...
Primary cutaneous diffuse large B-cell lymphoma, leg type usually grows fast and has a poor prognosis. This type has a high relapse rate and may spread beyond ...
Diffuse midline gliomas are especially common in children, where they make up most malignant brainstem tumors. Historically, in children these tumors were ...
An assessment of Mayo Clinic's new approach to radiation therapy for diffuse midline glioma. Laboratory studies of potential new therapies and drug-delivery ...
The purpose of this study is to determine the efficacy and safety of CTL019 in adult patients with relapsed or resistant diffuse large B-cell lymphoma.
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma · Overview · Participation ...
MRI with and without contrast can help identify common tumor types, including diffuse midline glioma (DMG) and other gliomas that can form in the brainstem. MRI ...
Travis E. Grotz, M.D., Surgical Oncologist: At Mayo Clinic, we treat all types of stomach cancer. One of the most common types of stomach cancer is the diffuse ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.